Societal Debates About Emerging Genetic Technologies: Toward a Science of Public Engagement
By Christopher D. Wirz,
Environmental Communication
| 09. 29. 2020
Gene editing is an inherently wicked problem
Societal debates about the applications of novel gene editing techniques like CRISPR in agriculture, wildlife, and humans have only rarely focused on questions that have correct or even factual answers. Of course, many discussions within the bench scientific community are focused on technical risks and benefits and the weighing of the latter against the former in the desire to develop climate- or pest-resistant crops (National Academies of Sciences, 2016) or therapies for devastating genetically-inherited diseases in humans (National Academy of Sciences & National Academy of Medicine, 2017).
While public debates are ideally informed by these scientific considerations, they are – by nature – much broader in scope. Gene drives developed to limit the spread of vector-borne illness carried by mosquitos, for instance, have raised concerns about the morality of “messing with nature” by editing the genome of living organisms for dominant traits, about creating imbalances in already fragile ecosystems, and about unintended and potentially irreversible long-term consequences for humans and nature (Brossard et al., 2019). At the same time, pesticides...
Related Articles
By staff, Japan Times | 12.04.2025
Japan plans to introduce a ban with penalties on implanting a genome-edited fertilized human egg into the womb of a human or another animal amid concerns over "designer babies."
A government expert panel broadly approved a proposal, including the ban...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Tina Stevens, CounterPunch | 12.11.2025
Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically engineered (GE) babies, according to a recent Wall Street Journal (WSJ) report. AI mogul Sam Altman, cryptocurrency entrepreneur Brian Armstrong, venture capitalist Peter...
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...